Immunologic reactions and Australia Antigenemia in Down's Syndrome

Siegel, 1948, Susceptibility of mongoloids to infection; incidence of pneumonia, Influenza A and Shigella dysenteriae (Sonne), Am J Hyg, 48, 53 Siegel, 1948, Susceptibility of mongoloids to infection; antibody response to tetanus toxoid and typhoid vaccine, Am J Hyg, 48, 63 Kirman, 1964, The patient with Down's syndrome in the community, Lancet, 2, 705, 10.1016/S0140-6736(64)92537-1 Donner, 1954, Study of immunology and biology of mongolism, Am Med Exper Biol Fenniae, 32, 1 Oster, 1964, The mortality and causes of death in patients with Down's syndrome (mongolism), 1, 231 Sutnick, 1972, Persistent anicteric hepatitis with Australia antigen in patients with Down's syndrome, Am J Clin Path, 57, 2, 10.1093/ajcp/57.1.2 Szmuness, 1971, The epidemiology of serum hepatitis (SH) infections: a controlled study in two closed institutions, Am J Epidem, 94, 585, 10.1093/oxfordjournals.aje.a121357 Ferris, 1972, Australia antigen and Down's syndrome, Lancet, 1, 46, 10.1016/S0140-6736(72)90044-X Blumberg, 1967, A serum antigen (Australia antigen) in Down's syndrome, leukemia and hepatitis, Ann Int Med, 66, 924, 10.7326/0003-4819-66-5-924 Blumberg, 1970, Australia antigen, hepatitis virus and Down's syndrome, Ann NY Acad Sci, 171, 486, 10.1111/j.1749-6632.1970.tb39358.x Agarwal, 1970, DNA polymerase activity as an index of lymphocyte stimulation: studies in Down's syndrome, J Clin Invest, 49, 161, 10.1172/JCI106215 Scheidegger, 1955, Une micro-méthods de l'immunoélectrophorèse, Int Archs Allergy, 7, 103, 10.1159/000228215 Fowler, 1973, Response to stimulation in vitro of lymphocytes from patients with Down's syndrome, 144, 475 Hayakawa, 1968, Hyperblastic response to dilute PHA in Down's syndrome, Lancet, 1, 95, 10.1016/S0140-6736(68)90109-8 Rosner, 1973, Leukocyte function and serum immunoglobulins in Down's syndrome, NY State J of Med, 73, 672